While the 1.4 million increase took it to 14.9 million, less than a third of the target, sales will have to continue picking up pace if BAT is to achieve its goal. The company also aims to achieve annual revenues of £5bn from three new products – Vuse vapes, Velo oral nicotine pouches and Glo heated tobacco, by the same date. This will require significantly higher growth than it achieved last year, when it reported sales in that category of £1.4bn, up 15% year on year.
BAT publishes comprehensive review on e-cigarettes
Earlier this year on the event of World Vape Day which fell on the 30th of May, the tobacco company published a comprehensive review of the scientific evidence for vaping products, and their potential in Tobacco Harm Reduction and decreasing smoking rates.
“This paper is a comprehensive summary of more than 300 peer-reviewed scientific papers and other evidence published by an estimated 50 institutions over the past decade,” said Dr David O’Reilly, Director of Scientific Research, Research and Development-British American Tobacco.
Sadly, the compiled data has indicated that over the past decade, the number of people who incorrectly believe vaping is as harmful or more harmful than smoking conventional cigarettes has risen in the UK, Europe, and the U.S.
Yet on a positive note, population modeling studies cited in the review, have shown that a significant reduction in premature deaths could be achieved if current smokers switched exclusively to vaping rather than continuing to smoke.
Read Further: The Guardian
BAT Accused of Using Legal loophole to Give Vape Samples to Minors
